Ovelle Bio Corp. funding
Ovelle Bio Corp., a biotechnology company based in Dover, DE (founded 2024), filed a Form D with the SEC on June 10, 2026 and reported $7M raised of a $9.2M offering.
Amount raised$7M
Offering size$9.2M
Filed with the SECJune 10, 2026
First saleJune 2, 2026
IndustryBiotechnology
SecuritiesEquity
LocationDover, DE
Founded2024
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeNo Revenues
View the original Form D on SEC EDGAR ↗ · All rounds filed Jun 10
Other health care rounds in Delaware
Vantage Health, Inc.$2.5M · Oct 2Other Health CareTuraco Inc.$1.2M · Oct 8Health InsuranceChemoMouthpiece, LLC$400K · Oct 30Other Health CareCare Nimble, Inc.$275K · Nov 12Other Health CareGiftWellSoon, LLC$75K · Nov 6Other Health CareHygia Technologies, Inc.$75K · Sep 15Other Health CareGlauc Inc.$50K · Sep 15Other Health CareMeca Industries Corp$37.5K · Sep 21Other Health Care